Skip to main content

Table 2 Cumulative incidence rate of death factors in patients with prostate cancer by Gray’s test

From: Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis

Variables P CIF 95%CI
Lower Upper
Race     
 Ethnic Chinese 0.021 5.96 4.86 7.20
 Other Asian-Americans   7.42 6.76 8.11
Age at diagnosis     
 < 65 < 0.001 4.90 4.12 5.76
 ≥ 65   8.52 7.74 9.35
Marital status     
 Married < 0.001 6.67 6.02 7.35
 Unmarried, single or widowed   8.72 7.47 10.08
Grade     
 I < 0.001 3.07 2.39 3.89
 II   10.26 9.41 11.15
T stage     
 T1 < 0.001 6.63 5.69 7.67
 T2   6.00 5.27 6.80
 T3   10.95 8.89 13.25
 T4   37.28 30.01 44.54
N stage     
 N0 < 0.001 6.48 5.91 7.08
 N1   40.22 33.84 46.51
M stage     
 M0 < 0.001 5.67 5.13 6.24
 M1   65.17 51.15 78.37
Radiotherapy     
 No < 0.001 6.92 6.34 7.53
 Yes   13.21 9.73 17.22
Chemotherapy     
 No < 0.001 7.00 6.42 7.61
 Yes   31.66 21.04 42.79
Surgery     
 No < 0.001 9.01 8.17 9.91
 Yes   4.25 3.67 4.89
Regional nodes positive     
 No < 0.001 3.02 2.29 3.89
 Yes   8.25 7.55 8.99
Histological types     
 Adenocarcinoma 0.611 7.20 6.61 7.83
 Squamous-cell carcinoma, mucinous carcinoma or sarcoma   6.00 3.68 9.10
  1. CIF cumulative incidence function, CI confidence interval